Yahoo Finance • a month ago
WILMINGTON, Del., April 11, 2024--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) announced today that it has scheduled its first quarter financial results conference call and webcast for 8:00 a.m. ET on Tuesday, April 30, 2024. The schedule for th... Full story
Yahoo Finance • 2 months ago
In this piece, we will take a look at the 12 best S&P 500 stocks to buy according to analysts. If you want to skip our coverage of the latest happenings surrounding one of America's most widely followed stock indexes, then you can take a l... Full story
Yahoo Finance • 2 months ago
WILMINGTON, Del., March 29, 2024--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) announced today that it granted equity inducement awards to Matteo Trotta, the Company’s new Executive Vice President and General Manager of U.S. Dermatology, pursuant... Full story
Yahoo Finance • 3 months ago
Two late-breaking abstracts have been accepted for oral presentation, including randomized studies evaluating ruxolitinib cream (Opzelura®) in hidradenitis suppurativa and povorcitinib (INCB54707) in prurigo nodularis Analyst and investor... Full story
Yahoo Finance • 3 months ago
WILMINGTON, Del., February 15, 2024--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) announced today that it will present at the Cowen 44th Annual Health Care Conference on Monday, March 4, 2024 at 9:50 a.m. (EST) in Boston. The presentation will b... Full story
Yahoo Finance • 3 months ago
In-depth examination of Incyte Corp's strengths, including its robust product portfolio and market leadership in Hematology/Oncology. Analysis of potential weaknesses and areas for improvement, such as reliance on key products and market c... Full story
Yahoo Finance • 3 months ago
Novartis agreed late Monday to buy MorphoSys for about $2.9 billion. The cancer-focused biotech stock catapulted to a nearly three-year high. Continue reading... Full story
Yahoo Finance • 4 months ago
In a recent transaction filed with the SEC, Steven Stein, EVP & Chief Medical Officer of Incyte Corp (NASDAQ:INCY), sold 7,365 shares of the company on January 3, 2024. The transaction was disclosed in a SEC Filing. Warning! GuruFocus has... Full story
Yahoo Finance • 5 months ago
In this piece, we will take a look at the 12 most promising gene editing stocks according to hedge funds. If you want to skip our take on how the gene editing industry sits right at the top of the global innovation food chain, then you can... Full story
Yahoo Finance • 5 months ago
- Trial met its primary endpoint across all dose cohorts with 74% of patients at the 0.3 mg/kg dose achieving a complete or partial response within the first six months of treatment - Data are featured in the Plenary Scientific Session at... Full story
Yahoo Finance • 6 months ago
Significant Addition to BeiGene Holdings BAKER BROS. ADVISORS LP (Trades, Portfolio), a prominent investment firm, has recently expanded its investment in BeiGene Ltd (NASDAQ:BGNE) with a substantial acquisition of shares. On November 14,... Full story
Yahoo Finance • 6 months ago
In this article, we will be taking a look at the top 20 drug companies in the US by revenue. To skip our detailed analysis, you can go directly to see the Top 5 Drug Companies in the US by Revenue. Following the Covid-19 pandemic, which d... Full story
Yahoo Finance • 7 months ago
– Sixteen oral presentations, as well as a plenary session and poster presentations, highlight new advances across eight of the Company’s medicines – Plenary Scientific Session will feature the full data from AGAVE-201 evaluating axatilim... Full story
Yahoo Finance • 7 months ago
WILMINGTON, Del., October 27, 2023--(BUSINESS WIRE)--Science magazine announced today that for the sixth consecutive year, Incyte has been named a top five employer based on its annual survey of approximately 6,800 individuals. Incyte rank... Full story
Yahoo Finance • 7 months ago
MONTREAL, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Brazilian affiliate, United Medical Ltd., has received pricing... Full story
Yahoo Finance • 7 months ago
MONTRÉAL, 16 oct. 2023 (GLOBE NEWSWIRE) -- Thérapeutique Knight inc. (TSX : GUD) (« Knight » ou la « Société »), société pharmaceutique spécialisée panaméricaine (hors États-Unis), a annoncé aujourd’hui que sa société affiliée brésilienn... Full story
Yahoo Finance • 7 months ago
PALM BEACH, Fla., Oct. 12, 2023 (GLOBE NEWSWIRE) -- FinancialNewsMedia.com News Commentary - Significant influences driving the CAR T-cell therapy market is a rising demand for model therapeutics for treatment of cancer, increase in prev... Full story
Yahoo Finance • 7 months ago
MONTREAL, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Brazilian affiliate, United Medical Ltd., has submitted a mark... Full story
Yahoo Finance • 7 months ago
MONTRÉAL, 10 oct. 2023 (GLOBE NEWSWIRE) -- Thérapeutique Knight inc. (TSX : GUD) (« Knight » ou la « Société »), société pharmaceutique spécialisée panaméricaine (hors États-Unis), a annoncé aujourd’hui que sa société affiliée brésilienn... Full story
Yahoo Finance • 8 months ago
In this article, we will be taking a look at the 13 best beaten down stocks to buy now. To skip our detailed analysis of the US stock market and recent developments within it, you can go directly to see the 5 Best Beaten Down Stocks To Buy... Full story
Home
Money Search
Trending Sports
Gallery
Shop
Blog
Examples
Data & Glossary
Elements of Bball
Harden Maze
About
